Spero Therapeutics, Inc. (SPRO)

2.33 0.00 (0.00%) USD  |  NASDAQ  |  Dec 24, 12:28
More

Spero Therapeutics SG&A Expense (TTM): 23.93M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for SPRO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
BioMarin Pharmaceutical, Inc. 973.41M
Amicus Therapeutics, Inc. 353.07M
Cassava Sciences, Inc. 68.06M
Omeros Corp. 44.20M
GeoVax Labs, Inc. 6.16M